REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

"Roche Polska" Sp. z o.o. (Poland)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: "Roche Polska" Sp. z o.o. Profile Updated: October 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Roche Polska Sp. z o.o. manages global clinical trials in 11 countries of Central and Eastern Europe, focusing on developing medical diagnostics. They are currently working on a global randomized double-blind placebo-controlled phase III clinical trial with the use of Tocilizumab in hospitalized patients with severe pneumonia in the UK.

Headquarters
Ul. Domaniewska 28
Warsaw; Mazowieckie; Postal Code: 02-672

Contact Details: Purchase the "Roche Polska" Sp. z o.o. report to view the information.

Website: http://www.roche.pl

Basic Information
Total Employees:
Purchase the "Roche Polska" Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the "Roche Polska" Sp. z o.o. report to view the information.
Registered Capital:
Purchase the "Roche Polska" Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the "Roche Polska" Sp. z o.o. report to view the information.
Incorporation Date:
June 14, 2002
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after "Roche Polska" Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
12.88%▲
Total operating revenue
10.97%▲
Operating profit (EBIT)
-21.73%▼
EBITDA
-20.51%▼
Net Profit (Loss) for the Period
26.81%▲
Total assets
36.78%▲
Total equity
24.34%▲
Operating Profit Margin (ROS)
-1.8%▼
Net Profit Margin
0.56%▲
Return on Equity (ROE)
0.38%▲
Quick Ratio
-0.1%▼
Cash Ratio
-0%

Similar companies

Zaklady Farmaceutyczne "Polpharma" S.A.
 
Lek S.A.
Bayer Sp. z o.o.
 
Teva Operations Poland Sp. z o.o.
Adamed Pharma S.A.
 
Centrala Farmaceutyczna "Cefarm" S.A.
Aflofarm Farmacja Polska Sp. z o.o.
 
Delpharm Poznan S.A.
"Usp Zdrowie" Sp. z o.o.
 
Sanofi Sp. z o.o.

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo